Found: 79
Select item for more details and to access through your institution.
Novel Therapeutic Avenues in Myeloma: Changing the Treatment Paradigm.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 7, p. 785
- By:
- Publication type:
- Article
Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy.
- Published in:
- Journal of Biomedical Optics, 2011, v. 16, n. 1, p. 011006, doi. 10.1117/1.3520571
- By:
- Publication type:
- Article
Biological properties of extracellular vesicles and their physiological functions.
- Published in:
- Journal of Extracellular Vesicles, 2015, v. 4, p. 1, doi. 10.3402/jev.v4.27066
- By:
- Publication type:
- Article
Publisher Correction: Patient preferences for intervention in the setting of precursor multiple myeloma.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Patient preferences for intervention in the setting of precursor multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01161-0
- By:
- Publication type:
- Article
Patient preferences for intervention in the setting of precursor multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01161-0
- By:
- Publication type:
- Article
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.
- Published in:
- 2013
- By:
- Publication type:
- journal article
BM mesenchymal stromal cell--derived exosomes facilitate multiple myeloma progression.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 4, p. 1542, doi. 10.1172/JCI66517
- By:
- Publication type:
- Article
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 3, p. 1542, doi. 10.1172/JCI66517
- By:
- Publication type:
- Article
Front line treatment of elderly multiple myeloma in the era of novel agents.
- Published in:
- Biologics: Targets & Therapy, 2009, v. 3, p. 99
- By:
- Publication type:
- Article
Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 3, p. 419
- By:
- Publication type:
- Article
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 222, doi. 10.1111/bjh.15261
- By:
- Publication type:
- Article
Current use of monoclonal antibodies in the treatment of multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 447, doi. 10.1111/bjh.15121
- By:
- Publication type:
- Article
Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 5, p. 717, doi. 10.1111/bjh.14743
- By:
- Publication type:
- Article
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 6, p. 929, doi. 10.1111/bjh.14493
- By:
- Publication type:
- Article
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 709, doi. 10.1111/bjh.13883
- By:
- Publication type:
- Article
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 843, doi. 10.1111/bjh.13382
- By:
- Publication type:
- Article
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 851, doi. 10.1111/bjh.13383
- By:
- Publication type:
- Article
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 401, doi. 10.1111/bjh.12909
- By:
- Publication type:
- Article
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-71
- By:
- Publication type:
- Article
Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0110973
- By:
- Publication type:
- Article
Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066982
- By:
- Publication type:
- Article
MGUS and Smoldering Myeloma: the Most Prevalent of Plasma Cell Dyscrasias.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 7, p. 594
- By:
- Publication type:
- Article
Tailoring Treatment for Multiple Myeloma Patients With Relapsed and Refractory Disease.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 3, p. 22
- By:
- Publication type:
- Article
Dietary Pattern and Risk of Multiple Myeloma in Two Large Prospective US Cohort Studies.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 2, p. N.PAG, doi. 10.1093/jncics/pkz025
- By:
- Publication type:
- Article
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1554, doi. 10.3390/cancers12061554
- By:
- Publication type:
- Article
Clinical perspective: Linking psychosocial care to the disease continuum in patients with multiple myeloma.
- Published in:
- Palliative & Supportive Care, 2015, v. 13, n. 4, p. 829, doi. 10.1017/S1478951514000649
- By:
- Publication type:
- Article
Myeloma Microenvironment.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S25
- By:
- Publication type:
- Article
High-Resolution Genomic Analysis in Waldenström's Macroglobulinemia Identifies Disease-Specific and Common Abnormalities with Marginal Zone Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 39
- By:
- Publication type:
- Article
Role of Proteasome Inhibition in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 94
- By:
- Publication type:
- Article
Balancing Risk Versus Benefit in the Treatment of Waldenström's Macroglobulinemia Patients with Nucleoside Analogue–Based Therapy.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 71
- By:
- Publication type:
- Article
Novel Therapeutic Agents in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 84
- By:
- Publication type:
- Article
Targeting the bone marrow microenvironment in multiple myeloma.
- Published in:
- Immunological Reviews, 2015, v. 263, n. 1, p. 160, doi. 10.1111/imr.12233
- By:
- Publication type:
- Article
microRNA Aberrations in Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 205, doi. 10.1016/j.clml.2013.02.007
- By:
- Publication type:
- Article
The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 218, doi. 10.1016/j.clml.2013.02.006
- By:
- Publication type:
- Article
Targeting the Bone Marrow in Waldenstrom Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, p. S65, doi. 10.1016/j.clml.2011.03.022
- By:
- Publication type:
- Article
Novel M-component based biomarkers in Waldenström's macroglobulinemia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
The Bone Marrow Niche in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 118, doi. 10.3816/CLML.2011.n.025
- By:
- Publication type:
- Article
Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 164, doi. 10.3816/CLML.2011.n.039
- By:
- Publication type:
- Article
Key Role of MicroRNAs in Waldenström's Macroglobulinemia Pathogenesis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 109, doi. 10.3816/CLML.2011.n.022
- By:
- Publication type:
- Article
The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 5, p. 446, doi. 10.1111/j.1600-0609.2012.01765.x
- By:
- Publication type:
- Article
The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 1, p. 1, doi. 10.1111/j.1600-0609.2011.01721.x
- By:
- Publication type:
- Article
Update on therapeutic options in Waldenström macroglobulinemia.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 1, p. 1, doi. 10.1111/j.1600-0609.2008.01171.x
- By:
- Publication type:
- Article
Proteomics analysis in post-transplant lymphoproliferative disorders.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 4, p. 298, doi. 10.1111/j.1600-0609.2008.01106.x
- By:
- Publication type:
- Article
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 6, p. 503, doi. 10.1111/j.1600-0609.2008.01060.x
- By:
- Publication type:
- Article
Waldenström macroglobulinemia.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Initial immunoglobulin M flare after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemiaThe current study was conducted by the Eastern Cooperative Oncology Group (Dr. Robert L. Comis, Chairman).: An Eastern Cooperative Oncology Group Study
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 11, p. 2593, doi. 10.1002/cncr.20658
- By:
- Publication type:
- Article
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 11, p. 2403
- By:
- Publication type:
- Article
Autologous graft versus myeloma: it's not a myth.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Use of Silk as a Scaffold for Mature, Sustainable Unilocular Adipose 3D Tissue Engineered Systems.
- Published in:
- Advanced Healthcare Materials, 2016, v. 5, n. 13, p. 1167, doi. 10.1002/adhm.201600211
- By:
- Publication type:
- Article